» Articles » PMID: 28791418

TRPM7 is Overexpressed in Bladder Cancer and Promotes Proliferation, Migration, Invasion and Tumor Growth

Overview
Journal Oncol Rep
Specialty Oncology
Date 2017 Aug 10
PMID 28791418
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Recent findings suggest that the melastatin transient receptor potential channel 7 (TRPM7) is overexpressed in many types of cancers and is involved in tumorigenesis. However, its expression pattern and the potential role in bladder cancer remain unclear. The aim of the present study was to investigate the expression status of TRPM7 and its relationship with the development of bladder cancer. In the present study, we observed that the expression of TRPM7 was significantly elevated in bladder cancer tissues compared with that noted in the adjacent non-tumor tissues. Furthermore, increased TRPM7 expression was significantly associated with recurrence, metastasis and prognosis. In addition, after knockdown of the expression of TRPM7 by siRNA, the proliferation and the motility of T24 and 5637 cells were obviously inhibited, and downregulation of TRPM7 was found to play an important role in bladder cancer cell apoptosis. In conclusion, our findings suggest that TRPM7 plays an important role in bladder cancer, and TRPM7 may serve as a potentially unfavorable factor and novel target for human bladder cancer.

Citing Articles

The PACT Network: PRL, ARL, CNNM, and TRPM Proteins in Magnesium Transport and Disease.

Jolly J, Blackburn J Int J Mol Sci. 2025; 26(4).

PMID: 40003994 PMC: 11855589. DOI: 10.3390/ijms26041528.


The Role of TRPM7 in Oncogenesis.

Koles L, Ribiczey P, Szebeni A, Kadar K, Zelles T, Zsembery A Int J Mol Sci. 2024; 25(2).

PMID: 38255793 PMC: 10815510. DOI: 10.3390/ijms25020719.


Mechanosensitive Ion Channels: Their Physiological Importance and Potential Key Role in Cancer.

Otero-Sobrino A, Blanco-Carlon P, Navarro-Aguadero M, Gallardo M, Martinez-Lopez J, Velasco-Estevez M Int J Mol Sci. 2023; 24(18).

PMID: 37762011 PMC: 10530364. DOI: 10.3390/ijms241813710.


LncRNA DGUOK-AS1 facilitates non-small cell lung cancer growth and metastasis through increasing TRPM7 stability via m6A modification.

Feng Y, Wu F, Wu Y, Guo Z, Ji X Transl Oncol. 2023; 32:101661.

PMID: 37037089 PMC: 10120365. DOI: 10.1016/j.tranon.2023.101661.


On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications.

Ciaglia T, Vestuto V, Bertamino A, Gonzalez-Muniz R, Gomez-Monterrey I Front Oncol. 2023; 12:1065935.

PMID: 36844925 PMC: 9948629. DOI: 10.3389/fonc.2022.1065935.


References
1.
Clapham D, Runnels L, Strubing C . The TRP ion channel family. Nat Rev Neurosci. 2001; 2(6):387-96. DOI: 10.1038/35077544. View

2.
Chen J, Luan Y, You C, Chen X, Luo R, Li R . TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca(2+) influx. Cell Calcium. 2010; 47(5):425-32. DOI: 10.1016/j.ceca.2010.03.003. View

3.
Meng X, Cai C, Wu J, Cai S, Ye C, Chen H . TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway. Cancer Lett. 2013; 333(1):96-102. DOI: 10.1016/j.canlet.2013.01.031. View

4.
Al-Zalabani A, Stewart K, Wesselius A, Schols A, Zeegers M . Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol. 2016; 31(9):811-51. PMC: 5010611. DOI: 10.1007/s10654-016-0138-6. View

5.
Ye F, Wang L, Castillo-Martin M, McBride R, Galsky M, Zhu J . Biomarkers for bladder cancer management: present and future. Am J Clin Exp Urol. 2014; 2(1):1-14. PMC: 4219291. View